DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Acceleron Pharma Inc. (XLRN)
« Back to company indexXLRN Chatter Timeline
Stock Ticker for XLRN
Most Active Tweeters for XLRN
No tweets foundRecent Tweets for XLRN
 |
@dailypoliticaln $3.49 Million in Sales Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/BIK4j0SLZW August 22nd 2018, 12:08am |
 |
@WatchlistN Zacks: Brokerages Anticipate Acceleron Pharma Inc $XLRN Will Announce Earnings of -$0.67 Per Share https://t.co/XvUVVFs85R August 22nd 2018, 12:08am |
 |
@MareaInformativ -$0.67 Earnings Per Share Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/sTspyLrG2w August 22nd 2018, 12:08am |
 |
@TickerReport $3.49 Million in Sales Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/C9nSMLx04i August 22nd 2018, 12:08am |
|
@MareaInformativ Acceleron Pharma Inc $XLRN Holdings Cut by Alps Advisors Inc. https://t.co/dOKGyuuoiU August 22nd 2018, 12:08am |
 |
@IlliniJJ $XLRN sold 50% of position at $48.89, want to get back in at a lower cost in the next 30 days. August 21st 2018, 4:08pm |
 |
@Biorunner1 $XLRN resistance @ $49.15+_ and then it runs August 21st 2018, 2:08pm |
 |
@keiner15780853 Binance reopen limited user registration Register link and BONUS ? https://t.co/8ML537TLGp ? 08/20 10:01 $XLRN… https://t.co/HjQTuwxBvm August 20th 2018, 10:08pm |
 |
@AmericanBanking Head to Head Analysis: Audentes Therapeutics $BOLD & Acceleron Pharma $XLRN https://t.co/XECZJNYKKg #stocks August 20th 2018, 12:08pm |
|
@MareaInformativ Head to Head Analysis: Audentes Therapeutics $BOLD & Acceleron Pharma $XLRN https://t.co/9pQTJYdyI4 August 20th 2018, 12:08pm |
 |
@TranscriptDaily Head to Head Analysis: Audentes Therapeutics $BOLD & Acceleron Pharma $XLRN https://t.co/BUiRCuyWKt August 20th 2018, 12:08pm |
 |
@Biotech2050 @tgtxdough $CELG & $XLRN might be looking at these #CKD #anemia statistics to decide on #sotatercept Keep us poste… https://t.co/4KlZWM9gjq August 20th 2018, 12:08am |
 |
@EnterpriseLeade Acceleron Pharma Inc $XLRN Receives $51.50 Average Target Price from Analysts https://t.co/zoKHafDuOp August 19th 2018, 11:08am |
 |
@SwingTradeBot Recent $XLRN technical alerts: NR7 plus 4 more alerts... https://t.co/9CITuDOmfh August 19th 2018, 9:08am |
 |
@1MinuteStock Recommendation #HOLD for $XLRN with UB rating - 2.25 out of 5. https://t.co/V323QXjJDi August 19th 2018, 8:08am |
|
@1MinuteStock Btw, Estimated #Earnings Per Share for $XLRN is $-0.64 it's -1.32% of the current price https://t.co/wB8VJQrjbz August 19th 2018, 8:08am |
 |
@bbnsnews -$0.67 Earnings Per Share Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/nzSYRMpUJg August 19th 2018, 8:08am |
 |
@j_jccnidan $XLRN FYI you can see these in Yahoo Finance August 19th 2018, 6:08am |
|
@j_jccnidan $XLRN What’s even more interesting is that a trader either sold his December Puts or converted them to Calls...Hmmm Fireworks coming........ August 19th 2018, 6:08am |
 |
@MarketChmln $XLRN option volume was 6X normal on Friday with 3,178 contracts. Call volume was 89% and put volume was 11%. https://t.co/ykkzoFtmpS August 18th 2018, 8:08pm |
 |
@ConsumerFeed Analysts Anticipate Acceleron Pharma Inc $XLRN Will Post Quarterly Sales of $3.49 Million https://t.co/G026ZvCpd5 August 18th 2018, 4:08am |
|
@AmericanBanking Acceleron Pharma Inc $XLRN Expected to Announce Quarterly Sales of $3.49 Million https://t.co/1j87MNh5dH #stocks August 18th 2018, 4:08am |
 |
@registrarjourn Acceleron Pharma $XLRN Receives Media Impact Rating of 0.05 https://t.co/6PntW4tzXB August 17th 2018, 5:08am |
|
@EnterpriseLeade Acceleron Pharma $XLRN Receives Media Impact Rating of 0.05 https://t.co/liSCjPjDah August 17th 2018, 5:08am |
 |
@ThisLincolnian Acceleron Pharma Inc $XLRN Given Consensus Recommendation of “Buy” by Brokerages https://t.co/ySRaifRP63 August 17th 2018, 12:08am |
|
@registrarjourn Acceleron Pharma $XLRN – Research Analysts’ Weekly Ratings Updates https://t.co/yThOAtdact August 16th 2018, 9:08am |
 |
@WeekHerald -$0.67 EPS Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/pWoPenYiQd August 16th 2018, 4:08am |
 |
@OlympiaReport Acceleron Pharma Inc $XLRN Expected to Announce Earnings of -$0.67 Per Share https://t.co/4BE0hi1cM3 August 16th 2018, 4:08am |
|
@AmericanBanking Acceleron Pharma Inc $XLRN Expected to Announce Earnings of -$0.67 Per Share https://t.co/z8i5fZydqS #stocks August 16th 2018, 4:08am |
|
@MareaInformativ Brokerages Anticipate Acceleron Pharma Inc $XLRN Will Announce Quarterly Sales of $3.41 Million https://t.co/3goPYpIwRf August 16th 2018, 4:08am |
|
@j_jccnidan $XLRN Interesting How the Volume picked up at the close and the bid is. Ow higher than the close Hmmmm August 15th 2018, 5:08pm |
|
@TickerReport Acceleron Pharma $XLRN vs. Crispr Therapeutics $CRSP Head to Head Analysis https://t.co/D5EAx7MnbJ August 15th 2018, 5:08pm |
 |
@The_CasualSmart Acceleron Pharma $XLRN Shareholder Sectoral Asset Management Decreased Position; Muhlenkamp & Co Raised Position in… https://t.co/3GnUlGLk6U August 15th 2018, 12:08pm |
 |
@usindexlive Acceleron Pharma $XLRN Shareholder Great Point Partners Boosted Its Stake; Holder Central Securities Has Lifted Gen… https://t.co/XpUoiFTnSY August 15th 2018, 8:08am |
|
@MareaInformativ Acceleron Pharma Inc $XLRN Position Lessened by Birchview Capital LP https://t.co/YTXjS2wuNN August 14th 2018, 9:08pm |
|
@OlympiaReport Acceleron Pharma Inc $XLRN Receives Consensus Rating of “Buy” from Analysts https://t.co/EaVvbtRr6B August 14th 2018, 9:08pm |
|
@registrarjourn Acceleron Pharma $XLRN Receiving Somewhat Positive News Coverage, Report Finds https://t.co/qOlMX9UNPD August 14th 2018, 2:08pm |
|
@EnterpriseLeade Acceleron Pharma $XLRN Receiving Somewhat Positive News Coverage, Report Finds https://t.co/S0wA2c4stn August 14th 2018, 2:08pm |
|
@j_jccnidan $XLRN People don’t understand that software does not tell them about the company. Most people are to lazy to listen to CC August 14th 2018, 8:08am |
 |
@RuggeroRespigo Ruggero Respigo : TD SELL $XLRN at 47.62, Supp 41.98 Resis 47.62 R13 HiLo 86% T1Y 57 buy 2.2 fwdPE -24.4 DIV N/A… https://t.co/wFYDpVXKH5 August 14th 2018, 3:08am |
 |
@a3igner TradeFlags : TD SELL $XLRN at 47.62, Supp 41.98 Resis 47.62 R13 HiLo 86% T1Y 57 buy 2.2 fwdPE -24.4 DIV N/A… https://t.co/X6wWUgj0pg August 14th 2018, 2:08am |
 |
@TradeFlags TD SELL $XLRN at 47.62, Supp 41.98 Resis 47.62 R13 HiLo 86% T1Y 57 buy 2.2 fwdPE -24.4 DIV N/A #Acceleron #stocks… https://t.co/T4ML4kFgz5 August 14th 2018, 2:08am |
|
@j_jccnidan $XLRN Buy on any weakness August 13th 2018, 6:08pm |
|
@WatchlistN Head to Head Comparison: Crispr Therapeutics $CRSP & Acceleron Pharma $XLRN https://t.co/1gYo442XhD August 13th 2018, 10:08am |
|
@j_jccnidan $XLRN Inverted H&S to retest highs https://t.co/ifkg99YDK6 August 13th 2018, 8:08am |
|
@The_CasualSmart Sectoral Asset Management Cut Acceleron Pharma $XLRN Position by $19.04 Million as Market Value Declined; Blackston… https://t.co/LhcOZiBwzG August 13th 2018, 6:08am |
 |
@ZolmaxNews Acceleron Pharma $XLRN Rating Increased to Hold at BidaskClub https://t.co/CzIiguxNWQ August 13th 2018, 2:08am |
 |
@bibeypost_stock Artal Group Sa Decreased Acceleron Pharma Inc $XLRN Stake By $36.00 Million - https://t.co/d3ucj0w6lj August 12th 2018, 8:08pm |
 |
@reurope_stock Artal Group Sa Decreased Acceleron Pharma Inc $XLRN Stake By $36.00 Million https://t.co/tmji8fVNis August 12th 2018, 8:08pm |
|
@The_CasualSmart Artal Group Sa Decreased Acceleron Pharma Inc $XLRN Stake By $36.00 Million https://t.co/xeEgzYyDE7 August 12th 2018, 8:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.